Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02043639 · ClinicalTrials.gov registry record
ClinicCompanion. Compared to the Use of a Goniometer
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 30
- Enrollment target
NCT02043639: Clinical Trial study, sponsored by Wake Forest University Health Sciences.
NCT02043639 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02043639 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 30 participants
- Enrollment target
Study Summary
In this study, the goal is to find out if the clinicCompanion™ is effective in measuring range of motion when compared to the goniometer. Currently, the goniometer is an approved device to measure range of motion by the FDA, but the clinicCompanion™ is not.
Primary Outcome
By freeing the doctor from data collection, he or she will be able to spend more time with patient discussing medical conditions and providing pertinent information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-02 |
Why NCT02043639 stopped before completion
NCT02043639 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02043639 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02043639 about?
NCT02043639 is a clinical study titled "ClinicCompanion. Compared to the Use of a Goniometer". In this study, the goal is to find out if the clinicCompanion™ is effective in measuring range of motion when compared to the goniometer. Currently, the goniometer is an approved device to measure range of motion by the FDA, but the clinicCompanion™ is not.
What is the current status of trial NCT02043639?
This trial is currently terminated. The enrollment target is 30 participants. The study started on 2013-08. Estimated completion is 2016-02.
Who is sponsoring clinical trial NCT02043639?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia